Mapp Biopharmaceutical, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Mapp Biopharmaceutical, Inc.
Quantité totale PI 20
Rang # Quantité totale PI 75 638
Note d'activité PI 2/5.0    13
Rang # Activité PI 66 911

Brevets

Marques

10 0
2 0
8 0
0
 
Dernier brevet 2025 - Antibodies against henipaviruses
Premier brevet 2012 - Monoclonal antibodies with alter...

Derniers inventions, produits et services

2024 Invention Antibodies against henipaviruses. Provided herein are Henipavirus antibodies. These Henipavirus ...
Invention Antibodies against henipaviruses. Provided herein are Henipavirus antibodies. These Henipavirus a...
Invention Antibodies against orthohantaviruses. Provided herein are hantivirus antibodies. These hantivirus...
2023 Invention Anti-respiratory syncytial virus antibodies, methods of their generation and use. Provided are a...
2021 Invention Anti-crimean-congo hemorrhagic fever virus antibodies, and methods of their generation and use. ...
2020 Invention Mrna-encoded antibodies for contraception. Non-hormonal contraception compositions and methods fo...
Invention Monoclonal antibodies and cocktails for treatment of ebola infections. Described herein are compo...
2019 Invention Monoclonal antibody cocktails for treatment of ebola infections. Antibody variants originating f...
2018 Invention Anti-respiratory syncytial virus antibodies, methods of their generation and use. Provided are an...
2017 Invention Monoclonal antibody cocktail for treatment of ebola infections. Antibody variants originating fro...
Invention Broadly protective antibody cocktails for treatment of filovirus hemorrhagic fever. This disclosu...
2016 Invention Monoclonal antibody cocktails for treatment of ebola infections. Antibody variants originating fr...
2012 Invention Monoclonal antibodies with altered affinities for human fcyri, fcyrllla, and c1q proteins. Disclo...
Invention Monoclonal antibodies with altered affinities for human fcyri, fcyriiia, and c1q proteins. Discl...